1. World Health Organization. Global tuberculosis report 2014. Geneva: WHO, 2014. WHO/HTM/TB/2014.08. http://www.who.int/tb/publications/global_report/en/.
2. Xpert®MTB/RIF assay: development, evaluation and implementation of a new rapid molecular diagnostic for tuberculosis and rifampicin resistance;Lawn;Future Microbiol,2011
3. UNITAID, World Health Organization. Tuberculosis: diagnostics technology and market landscape. 3rd edition. Geneva: WHO, 2014. http://www.unitaid.eu/images/marketdynamics/publications/UNITAID_TB_Diagnostics_Landscape_3rd-edition.pdf.
4. World Heath Organization. Molecular line probe assays for rapid screening of patients at risk of multidrug-resistant tuberculosis (MDR-TB) – policy statement. Geneva: WHO, 2008. http://www.who.int/tb/features_archive/policy_statement.pdf.
5. Evaluation ofthe INNO-LiPA Rif. TB assay, a reverse hybridization assay for the simultaneous detection of Mycobacterium tuberculosis complex and its resistance to rifampin;Rossau;Antimicrob Agents Chemother,1997